Arch Therapeutics, Inc. – Ticker: ARTH

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding
(hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products
based on an innovative self-assembling peptide technology platform to make surgery and interventional
care faster and safer for patients. Arch’s flagship development stage product candidate, known as the
AC5 Surgical Hemostatic Device, is being designed to achieve hemostasis in minimally invasive and open
surgical procedures.

Web Site: ArchTherapeutics.com

PublicWire

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

PublicWire on Instragram


Login to your account below

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.